Tullett Prebon PLC’s £1.1 billion deal to buy a voice-brokerage business from British rival ICAP PLC faces an inquiry from the UK’s competition watchdog.
The Competition and Markets Authority has referred the deal, which would significantly reshape the interdealer brokerage landscape in the U.K., for an “in-depth investigation” to determine if it reduces competition in the sector.
The investigation could take up to six months, a spokesperson for the regulator said on Tuesday.
The deal between longstanding rivals Tullett and ICAP, founded by high-profile City of London figure Michael Spencer, was announced in November last year.
The combination would create the world’s largest interdealer brokerage house with revenue of £1.5 billion a year. Interdealer brokers—which match buyers and sellers of securities on behalf of investment banks—have struggled since the financial crisis. Tougher financial regulations have crimped the trading activity of banks on which the brokers were heavily dependent.
Despite fierce competition in the sector, Mr. Spencer said in November that the two companies had become “a happily married couple”. Upon completion of the deal ICAP plans to begin trading as NEX Group with a focus on electronic trading and after-trading activities.
The CMA said its investigation will only focus on oil products where the merger might gives rise to “a realistic prospect of a substantial lessening of competition” as rivalry from other brokers is more limited.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas